How our evolutionary past could help guide drug therapies of the future

It is now well established that different human populations may exhibit very different responses to therapeutic drugs. However, to what extent this may have been influenced by our evolutionary history is less well known. In this guest blog, Ripudaman K Bains from University College London outlines why understanding our past can help inform our future, and describes her recent work published in BMC Genetics with colleagues from Addis Ababa University, Henry Stewart Group and Uppsala University on molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.
One of the most significant accomplishments of the genomics revolution has been an improvement in our understanding of why certain populations have elevated risks for developing specific diseases. …

